Creatine for Depression: What New 2026 Research Actually Shows
Key Takeaways
- A June 2026 systematic review from the University of Ottawa analyzed 5 randomized controlled trials on creatine and depression.
- When added to the antidepressant escitalopram, 5 g/day of creatine produced a large additional reduction in depressive symptoms (Cohen's d = 1.13).
- The evidence is promising but preliminary — the review pooled only 238 participants across 5 trials.
- Creatine is not a replacement for antidepressants or therapy — the benefit appears as an add-on treatment.
- The proposed mechanism is creatine's role in brain energy metabolism, particularly restoring phosphocreatine levels in the prefrontal cortex.
The Study: A Systematic Review of 5 Clinical Trials
A new systematic review published in the journal Brain Medicine on June 30, 2026, examined the available randomized controlled trial evidence on creatine supplementation as a treatment for depression. The lead author, Bassam Jeryous Fares from the University of Ottawa, and colleagues pooled data from five clinical trials covering 238 participants — 126 in creatine groups, 112 in placebo groups.
The trials were conducted across five countries: South Korea, the United States, Brazil, Israel, and India. Most participants were women — two of the five trials enrolled only women — and the average age was 36 years. Four trials focused on major depressive disorder; one included people with bipolar disorder in a depressive episode.
The review was reported widely in health media, including Fox News Health, as evidence that a common gym supplement might have an unexpected role in mental health treatment.
What the Trials Found
The results were not uniform across all five trials, but the signal in two of them was striking.
In a South Korean study of women with major depressive disorder, participants who added 5 grams of creatine per day to the antidepressant escitalopram experienced significantly greater reductions in depressive symptoms than those on escitalopram plus placebo. The effect size — Cohen's d of 1.13 on the Hamilton Depression Rating Scale — is considered large by clinical standards. More women in the creatine group also reached full remission.
A 2025 Indian study took a different approach: instead of combining creatine with medication, researchers added 5 g/day of creatine as an adjunct to cognitive behavioural therapy (CBT). After eight weeks, the creatine group showed significantly greater symptom improvement than the CBT-plus-placebo group.
The remaining three trials showed mixed or neutral results, which is why the authors described the overall evidence base as promising but preliminary. A pooled meta-analysis was not possible due to differences in study design, outcome measures, and participant populations across the five trials.
Why Creatine Might Help With Depression
The proposed mechanism connects creatine's well-established role in energy metabolism to how depression affects the brain.
The brain is exceptionally energy-demanding — it consumes roughly 20% of the body's total energy despite accounting for only 2% of body weight. The phosphocreatine system is one of the brain's primary short-term energy buffers, and the prefrontal cortex — the region most consistently implicated in depression — is particularly dependent on it.
Brain imaging studies using phosphorus MRS (magnetic resonance spectroscopy) have found that people with major depressive disorder often have lower phosphocreatine levels in the prefrontal cortex compared to healthy controls. This energy deficit is thought to impair the neural circuits that regulate mood, motivation, and emotional processing.
Creatine supplementation raises brain phosphocreatine levels — a fact established by multiple imaging studies in healthy volunteers. The working hypothesis is that restoring the brain's energy buffer helps these circuits function more normally, potentially augmenting the effect of antidepressants or psychotherapy.
Women appear to be particularly responsive, possibly because female sex hormones interact with creatine metabolism and brain energy regulation in ways that are still being investigated.
What This Research Cannot Yet Tell Us
The systematic review's authors were careful about the limits of their conclusions, and those limits are worth understanding clearly.
Small total sample size. 238 participants across five trials is a modest evidence base. Most individual trials had fewer than 60 participants per group — too small to draw firm population-level conclusions.
Heterogeneous populations. The trials enrolled different populations (Korean women, Indian adults, mixed-gender groups), used different antidepressants or psychotherapy frameworks, and measured outcomes with different scales. This makes it difficult to know how broadly the findings generalize.
Short durations. Most trials ran for 6–8 weeks. Whether creatine's benefits persist with longer treatment — or what happens when supplementation stops — is unknown.
Not a standalone treatment. In every trial that showed benefit, creatine was added to an existing treatment (antidepressant medication or therapy). There is no evidence that creatine alone is sufficient to treat depression. It appears to work as an augmentation strategy, not a replacement.
The authors called for larger, longer, and more diverse trials before creatine could be recommended as a clinical adjunct for depression.
What This Means for Canadians
Depression affects roughly 1 in 8 Canadians at some point in their lives, and a significant proportion of people with major depressive disorder do not achieve full remission with their first antidepressant. The search for safe, accessible augmentation strategies is genuinely important.
Creatine monohydrate is inexpensive (typically $30–60 for a 3–4 month supply in Canada), widely available at supplement retailers and pharmacies, and has an excellent safety record at standard doses. If future, larger trials confirm the preliminary signal from this systematic review, it could become a useful tool in the mental health toolkit.
For now, if you or someone you know is managing depression, creatine is not a self-prescribed substitute for professional care. Discuss it with a doctor or psychiatrist — particularly in the context of existing treatment — before adding it to a regimen. The evidence is early, but it is the kind of early evidence worth watching.
Creatine & Depression: The 2026 Research Summary
- 5 RCTs Randomized controlled trials analyzed
- 238 Total participants across all trials
- 5 g/day Creatine dose used in positive trials
- 1.13 Cohen's d effect size (escitalopram add-on trial) — considered large
- Preliminary Current evidence status — promising but not yet conclusive
Frequently Asked Questions
Can creatine help with depression?
Early research suggests creatine may augment existing depression treatments. A June 2026 systematic review from the University of Ottawa found that adding 5 g/day of creatine to an antidepressant (escitalopram) produced a large additional reduction in depressive symptoms in women with major depressive disorder. However, the evidence base is small (5 trials, 238 participants total) and preliminary. Creatine should not replace professional care.
What was the creatine depression study published in 2026?
A systematic review published in Brain Medicine (Genomic Press) on June 30, 2026, by lead author Bassam Jeryous Fares from the University of Ottawa analyzed five randomized controlled trials on creatine supplementation and depression. The review found promising but preliminary evidence that creatine as an add-on to antidepressants or therapy may improve outcomes, particularly in women.
Why would creatine affect depression?
The proposed mechanism involves brain energy metabolism. People with depression often have reduced phosphocreatine levels in the prefrontal cortex — the brain region most involved in mood regulation. Creatine supplementation raises brain phosphocreatine levels, potentially restoring the energy buffer that supports normal mood-regulating circuit function. This is thought to augment the effect of antidepressants or therapy.
How much creatine was used in the depression trials?
The trials that showed benefit used 5 grams of creatine monohydrate per day. This is the same standard daily maintenance dose recommended for athletic performance. In the depression trials, it was taken as an add-on to either an antidepressant medication or cognitive behavioural therapy.
Is creatine safe to take alongside antidepressants?
In the clinical trials reviewed, creatine at 5 g/day was used alongside antidepressants (specifically escitalopram) without reported serious adverse interactions. However, any decision to add a supplement to a prescription medication regimen should involve your prescribing doctor. Creatine is generally safe at standard doses but your specific health context matters.